Self-reactive T cells that escape negative selection in the thymus must be kept under control in the periphery. Mechanisms of peripheral tolerance include deletion or functional inactivation of self-reactive T cells and mechanisms of dominant tolerance mediated by regulatory T cells. In the absence of costimulation, T cell receptor (TCR) engagement results in unopposed calcium signaling that leads to the activation of a cell-intrinsic program of inactivation, which makes T cells hyporesponsive to subsequent stimulations. The activation of this program in anergic T cells is a consequence of the induction of a nuclear factor of activated T cells (NFAT)-dependent program of gene expression. Recent studies have offered new insights into the mechanisms responsible for the implementation and maintenance of T cell anergy and have provided evidence that the proteins encoded by the genes upregulated in anergic T cells are responsible for the implementation of anergy by interfering with TCR signaling or directly inhibiting cytokine gene transcription.
Introduction
T-cell mediated immunity relies on the ability of the T cell receptor (TCR) to recognize foreign antigens. To accomplish this goal, random rearrangements of the V(D)J segments at the TCR locus lead to the generation of an extraordinarily diverse TCR repertoire. However, this process can also generate dangerous self-reactive T cells bearing TCRs that can recognize self antigens. Although most self-reactive T cells are eliminated in the thymus, negative selection has limitations and additional mechanisms of tolerance are required to limit autoimmunity. Peripheral tolerance is achieved through different mechanisms that include the induction of anergy, suppression by regulatory T cells (Tregs) and peripheral deletion of self-reactive T cells. Anergy is a mechanism of peripheral tolerance that results in functional inactivation of self-reactive T cells [1] [2] [3] . Clonal T cell anergy can be induced upon engagement of the TCR in the absence of costimulatory signals [4] [5] [6] . Although the first characterization of T cell anergy was described 20 years ago, it has only been recently that the molecular mechanisms responsible for the functional inactivation of T cells have been characterized.
In this review, we will discuss evidence that supports that transcriptional regulation plays a crucial role in the induction and maintenance of T cell anergy. In response to an anergizing stimulus, specific transcriptional complexes activate the expression of a distinct calcium-dependent program of gene expression that is intrinsically different from the set of genes that are upregulated in activated T cells [7, 8] . One of the most important pathways in the transduction of calcium signals in T cells is the calcineurinmediated dephosphorylation of members of the nuclear factor of activated T cells (NFAT) family of transcription factors [9] [10] [11] . We will discuss evidence that supports that NFAT proteins play a key role in the induction of tolerance in T cells by driving the expression of anergy-inducing genes [7] . The expression of these genes is required to impose a state of functional unresponsiveness through different mechanisms that include, among others, downregulation of TCR signaling by inactivation or degradation of signaling molecules [12] .
One of the hallmarks of anergic T cells is their inability to synthesize IL-2 in response to TCR engagement [2] . Although this defect can be explained by events that lead to the blockade of signaling pathways downstream of the TCR, evidence suggests that direct transcriptional repression of the IL-2 gene expression also contributes to the general defect of IL-2 production in anergic T cells [13, 14] . Thus, the implementation and maintenance of anergy may also respond to the engagement of specific mechanisms of transcriptional repression that inhibit the expression of cytokine genes in anergic T cells [15] [16] [17] (Figs. 1 and 2) . TCR engagement without concomitant costimulation results in the unbalance activation of calcium signaling in the absence of full activation of other pathways (i.e. Ras/MAPK, PKC, IKK). Sustained increased intracellular calcium activates the calmodulin (CM) dependent phosphatase calcineurin (Cn) which dephosphorylates NFAT, exposing a nuclear localization signal (NLS) and inducing NFAT nuclear translocation. In the absence of AP-1 proteins, NFAT induces an anergy-inducing program of gene expression. NFAT also upregulates the expression of Egr2 and Egr3 (Egr) that contribute, in cooperation with NFAT or in an independent manner, to activate the expression of anergy-inducing genes. The proteins encoded by those genes (e.g. Itch, Grail, Cbl-b, DGK␣, Ikaros) will cause dampening of TCR signaling and IL-2 silencing in anergic T cells.
Anergic T cells activate distinct programs of gene expression
Early studies supported the idea that new protein synthesis was necessary for T cells to become unresponsive, as suggested by the difficulty to anergize T cell clones in the presence of cycloheximide [6] . The existence of anergizing factors was also made evident by the possibility of transferring the anergic phenotype in somatic fusions between an anergic mouse T cell and a human T cell. These experiments indicated that anergic T cells were able to produce dominant repressor molecules [18] . Genome wide analysis of gene expression using DNA microarray technology has revealed that anergic T cells, and also B cells, express a specific set of genes. The proteins encoded by those genes are responsible for dampening TCR signaling in anergic T cells [7, 8, 19] . Differential analysis of gene expression has been performed in vitro, using T cell clones and primary Th1 cells . In anergic T cells Ikaros binds to the IL-2 promoter and recruits histone deacetylases (HDAC). These enzymes would remove acetyl groups (Ac) from core nucleosome histones (H) leading to the establishment of epigenetic changes that result in stable silencing of the IL-2 gene expression. Other transcriptional repressors (i.e. CREM proteins and Smad3 (C/S)) may be activated by calcium or other signals and bind to the IL-2 promoter also inhibiting IL-2 expression. [7] ; and also in vivo: analyzing gene expression in TCR transgenic mice crossed with mice that express the cognate antigen [8, 20] , anergizing transgenic DO11.10 mice by oral administration of ovalbumin [7] , or using systemic administration of a superantigen to induce T cell tolerance [21] . All these reports provide conclusive evidence that the induction of T cell anergy is an active process that results from the activation of a specific program of gene expression in response to anergizing stimuli. As it will be discussed in this review and in other reviews in this issue, the analysis of the function of the proteins encoded by those genes has provided very valuable information to understand the molecular mechanisms involved in the implementation and maintenance of T cell anergy.
Calcium/NFAT signaling in T cell anergy
Three of the four calcium-regulated members of the NFAT family of transcription factors (NFAT1, 2 and 4) are expressed in T cells [10, 11, 22] . In resting cells, these proteins are heavily phosphorylated and reside in the cytosol. TCR engagement results in the activation of phospholipase C-gamma (PLC␥) and the production of inositol triphosphate, which induces depletion of intracellular calcium stores and the subsequent activation of store-operated calcium entry [23, 24] . Sustained increase of intracellular calcium induces the activation of the calmodulindependent phosphatase calcineurin, which docks at a specific motif (PxIxIT) in the N-terminus of NFAT and dephosphorylates multiple serine residues in the NFAT regulatory domain [25, 26] . Upon dephosphorylation, NFAT proteins undergo a conformational change that exposes their nuclear localization signals, leading to their translocation into the nucleus and the induction of NFAT-mediated gene transcription ( Fig. 1 ) [27] . Several kinases, including GSK3, CK1, DYRK and some mitogen activated protein kinases (MAPK), have been reported to be involved in the phosphorylation of NFAT transcription factors [28] [29] [30] [31] [32] [33] . These kinases control NFAT nuclear shuttling by phosphorylating distinct serine-containing motifs on different NFAT family members in the cytosol, to prevent nuclear translocation, or in the nucleus, to induce nuclear export. In stimulated T cells, NFAT proteins cooperate with members of the activator protein 1 (AP-1) family of transcription factors to elicit the expression of activation-induced genes [34] [35] [36] . Ternary complexes containing Fos, Jun and NFAT proteins are formed on NFAT:AP-1 composite sites, which are present in many genes induced in activated T cells [37, 38] . Cooperation of NFAT and AP-1 results from the integration of two of the major signaling pathways induced in response to T cell stimulation: calcium, which is responsible for NFAT activation, and Ras/MAP kinases, which induce expression or activation of Fos and Jun [36, 37] . In the classic two-signal model this integration occurs when the TCR (signal 1) and costimulatory molecules, such as CD28 (signal 2), are engaged. Stimulation of T lymphocytes by engagement of their antigen receptor (Signal 1) in the absence of co-stimulation leads to clonal anergy [1, 2] . The absence of CD28:B7 interaction leads to an unbalanced activation, where calcium-induced signaling pathways are fully activated, but those other pathways that require CD28 engagement (e.g. Ras-MAPK, PKC, and IKK) are only partially induced. Under these circumstances, NFAT proteins are responsible for the activation of a very specific program of gene expression that is responsible for the implementation of a hyporesponsive state in anergic T cells ( Fig. 1 ) [7] . Transcription of these genes is AP-1 independent, as it can be induced using the calcium ionophore ionomycin under conditions in which no AP-1 transcriptional complexes can be detected in the nucleus. The expression of those genes is, however, clearly dependent on NFAT, as it can be blocked with cyclosporine, an inhibitor of calcineurin, and it is markedly reduced when T cells from an NFAT1−/− mouse are anergized. Consequently, both situations lead to ineffective anergy induction. More strikingly, introduction of a constitutively active NFAT1 protein in Th1 cells renders them unresponsive to TCR engagement in a state resembling anergy, which responds to the upregulation of many anergy-associated genes [7] . The anergy-inducing program of gene expression includes, among others, E3 ubiquitn ligases, tyrosine phosphatases, diacylglycerol kinase alpha (DGK␣) and several transcriptional repressors [39] [40] [41] . Subsequent reports have confirmed that many of those genes, such as Itch, Cbl-b, GRAIL and DGK␣, are specifically upregulated in anergic T cells in a calcium dependent and cyclosporine sensitive manner. Moreover, those studies have provided direct experimental evidence of the crucial role of these proteins in T cell anergy [42] [43] [44] [45] [46] . These data support that T cell inactivation is achieved in anergic T cells through a calcium/NFATdependent transcriptional program that induces the expression of genes that mediate the simultaneous inhibition of several cellular processes involved in the cascade of events leading from TCR engagement to cytokine production and clonal expansion.
What are the NFAT-containing transcriptional complexes that upregulate the expression of anergy associated genes? Experiments in which introducing an active form of NFAT1 directed the expression of anergy associated genes suggested that, at least for those genes, complexes that contain only NFAT proteins could induce their transcription [7] . The nature of those complexes has not been characterized yet. Recently, it has been shown that on certain NFAT sites that bear homology to B binding elements, NFAT1 can bind as a dimer. The DNA binding domain of NFAT is structurally homologous to the Rel domain of NF-B proteins and two structures containing dimers of NFAT1 have been resolved on the B-like sites of the IL-8 promoter and the HIV1 long terminal repeat [47, 48] . It may be possible, thus, that dimer complexes of NFAT proteins may be responsible for the transcriptional activation of those genes. Results from our laboratory suggest that direct transcriptional activation of anergy-associated genes by NFAT dimers may occur in T cells when stimulated under anergizing conditions (SotoNieves et al., manuscript in preparation). It is unclear whether all NFAT family members may be able to activate an anergyinducing transcriptional program. Regions involved in dimer interaction and DNA binding are highly conserved among different NFAT family members, and it might be even possible that heterodimers between different NFAT family members could be formed. Although redundancy may be a factor in many of the T cell functions controlled by NFAT proteins, analysis of mice deficient in individual NFAT family members suggests that some functions may be regulated by specific NFAT family members. In particular, programs that negatively regulate T cell activation seem to be dependent on NFAT1 and NFAT4 [49] [50] [51] [52] [53] [54] . Further research will be needed to determine NFAT specificity in the regulation of T cell anergy.
Two sets of results support the possibility that NFAT may cooperate with other transcription factors to activate a full anergy-inducing program. First, NFAT alone is not able to activate the expression of all genes induced under anergizing conditions; and second, anergizing T cells using ionomycin, which is capable of fully activating NFAT proteins, induces a hyporesponsive state that, as opposed to clonal anergy induced by TCR engagement in the absence of costimulation, is short lived [2, 7] . It is quite likely then that other transcription factors, independently or cooperating with NFAT, may be involved in the regulation of the expression of anergy-inducing genes. NFAT proteins can cooperate not only with AP-1 transcription factors but also with a myriad of other proteins. These interactions are specific for certain conditions and tissues, and regulate different functions in T cells and other cell types [10, 11] . NFAT proteins act, thus, as integrators of calcium signaling with many other signaling pathways in T cells. The structure of a monomeric NFAT1 bound to DNA has recently been resolved, showing that the linker segment located between the N-terminal and the C-terminal regions of the DNA binding domain has a high degree of flexibility. Because of this flexibility, NFAT1:DNA complexes can acquire different structural conformations, which could explain how NFAT is able to interact with different transcriptional partners [55] . Protein-protein interactions have been described between NFAT and proteins belonging to several other families of transcription factors. Synergy between NFAT and cMaf occurs at the IL-4 promoter [56] , and between NFAT and GATA3 at a 3 IL4 enhancer [57] . Synergistic interactions have also been reported with IRF-4 in the IL-4 promoter [58] and with T-bet in an enhancer of the interferon gamma gene [57] . NFAT and MEF2 cooperation is involved in the expression of Nur77 in T cells and may also play a role in IL-2 transcription [59, 60] . Cooperation of NFAT proteins with any of those factors or new unidentified interactions may also be key to the regulation of the induction of T cell anergy.
The expression of Egr2 and Egr3 had previously been shown to be sensitive to cyclosporine and to respond to NFAT binding to specific sites in the promoters of the genes that encode these transcription factors [61] . Cooperation between NFAT and Egr2 and Egr3 was also shown to be required for proper Fas ligand (FasL) expression in T cells, as cells lacking NFAT1 and NFAT4 showed defective activation of a FasL promoter reporter, which was restored with a vector expressing NFAT1 [61] . Recently, it has been shown that the expression of Egr2 and Egr3 is upregulated and persists for longer times in anergic T cells compared with fully activated cells [62, 63] . Increased expression of these proteins can also be detected in an in vivo model of T cell anergy [63] . Moreover, Egr3 deficient cells are resistant to anergy induction. Egr3−/− T cells fail to upregulate the expression of Cbl-b in response to ionomycin, which suggests that Egr proteins may regulate the expression of anergy-inducing genes [63] . Therefore, Egr2 and Egr3 would be induced by NFAT in response to anergizing stimuli and would then activate the transcription of other anergy-inducing genes, such as Cbl-b (Fig. 1) . Whether Egr2 and Egr3 can activate the expression of Cbl-b and other genes as independent complexes or in cooperation with NFAT remains to be determined. The fact that Egr2 and Egr3 expression seems to be dependent on NFAT1 and NFAT4 but not on NFAT2 suggests, as discussed before, a specific role for these two NFAT family members in the induction of clonal T cell anergy [61] .
The involvement of NFAT proteins in the regulation of peripheral tolerance is not only limited to T cell anergy. Studies carried out in a well established model of B cell tolerance using transgenic mice that express anti HEL-Ig and a soluble form of this lysozyme have shown that NFAT1 can also regulate B cell anergy, as transgenic B cells from mice deficient in NFAT1 are inefficiently anergized in the presence of soluble HEL [64] .
The function of regulatory T cells (Treg) has also been recently shown to be regulated by NFAT. Dominant tolerance mediated by CD4+CD25+Tregs constitutes another key mechanism of peripheral tolerance. Tregs have the ability to suppress effector functions, such as IL-2 production and proliferation, in CD4+T cells [65] . The mechanisms underlying this form of suppression are still poorly understood. Natural CD4+CD25+Tregs are generated in the thymus, although recent evidence supports the extrathymic generation of bona fide Tregs in response to suboptimal stimulation [66] . The forkhead transcription factor Foxp3 has been identified as a hallmark of this population of suppressor cells. It is expressed almost exclusively in CD4+CD25+Tregs and mice deficient in Foxp3 fail to produce a normal population of Tregs and develop a multiorgan autoimmune disorder [67, 68] . In addition to Foxp3, Tregs also show upregulated expression of other markers such as CD25, CTLA-4 and GITR, although their role in the suppressor function of Tregs is not yet fully understood [65] . Foxp3 is thought to be the factor responsible for the pattern of gene expression that defines Tregs, but its mechanism of action has not been characterized yet. Recent experiments suggested that this protein might interact with NFAT and NF-B and inhibit their transcriptional activity [69] . A very elegant report has recently resolved the crystal structure of a complex containing the forkhead domain of Foxp2 and the DNA binding domain of NFAT1, demonstrating that Foxp proteins can associate in transcriptional complexes with NFAT transcription factors [70] . These experiments have also shown that these complexes bind to NFAT:AP1 composite sites on the IL-2 promoter and likely displace NFAT:AP-1 complexes, directly repressing IL-2 transcription. Foxp3 interaction with NFAT is crucial for Treg function, since the expression of a mutant Foxp3 unable to bind NFAT1 results in defective IL-2 repression and suppressor function in transfected T cells [70] . The IL-2 promoter region is not properly remodeled in Tregs and remains in an inactive closed state [71] . As Foxp3 has recently been shown to bind the promoters of the IL-2 and IFN␥ genes in a cyclosporine A sensitive way and actively induce histone deacetylation [72] , it is possible that NFAT:Foxp3 complexes might be involved in the induction of the epigenetic changes that result in IL-2 silencing in Tregs. Interestingly, NFAT:Foxp3 complexes can also activate transcription of CD25 and CTLA-4 [70] . The mechanisms that determine whether these complexes behave as repressors or activators and the possible role of NFAT:Foxp3 interactions during Treg generation in the thymus or in secondary lymphoid organs remain yet to be elucidated.
On the other side of the suppressor reaction, it has been reported that cells defective in NFAT1 and NFAT4 are resistant to suppression by Tregs [73] . Although it is not clear how these two NFAT family members may be involved in regulating T cell suppression, interaction with other transcription factors, may be responsible for this effect. NFAT proteins have been shown to cooperate with several transcriptional repressors, including ICER, a member of the CREB/CREM family of transcription factors, PPR␥ and p21 SNFT [74] [75] [76] . As it happens during anergy induction, the choice of NFAT transcriptional partners may underlie the different patterns of gene expression that are activated in CD4+T cells when they are stimulated in the presence or the absence of CD4+CD25+Tregs [77] . These results suggest that NFAT may not only control T cell inactivation by regulating the induction of anergy, but also suppression caused by regulatory T cells. Common pathways might there-fore be shared between these two mechanisms of peripheral T cell tolerance.
Mechanisms of transcriptional repression in the implementation and maintenance of T cell anergy
Initial molecular characterizations of T cell anergy identified a defect in the activation of the Ras/MAP kinase signaling pathway that could account for the defective activation of AP-1 in anergic T cells [78, 79] . Several mechanisms have been proposed to explain this block of TCR signaling. Proteins with ubiquitin ligase activity, including Itch, Grail and Cbl-b, have been implicated in the negative regulation of TCR signaling in anergic T cells [44] [45] [46] 80] . These enzymes can specifically target proteins, such as PLC␥, PKC or RhoGDI, leading to their functional inactivation or degradation [45, 81] . Upregulation of DGK␣ has also been recently shown to prevent MAPK activation in anergic T cells by increasing the conversion of diacylglycerol into phosphatidic acid [42, 43] .
Although all those proteins can cause severe signaling defects that would lead to defective TCR engagement-mediated upregulation of IL-2 expression, evidence suggested that an active mechanism of transcriptional repression that directly inhibited IL-2 transcription was also activated in anergic T cells. Studies using reporter vectors containing different fragments of the IL-2 promoter, identified several regions that were required to induce decreased expression when transfected into anergic T cell clones [13, 14] . A site located at the −180 position in the IL-2 promoter was later shown to bind CREB/CREM complexes in anergic T cells, suggesting that transcriptional inactive isoforms of CREM, such as ICER, could be forming repressor complexes with CREB bound to the IL-2 promoter [17, 82] . Repressor complexes formed by Bcl-3 and NF-B p50 homodimers have also been reported to bind to the IL-2 promoter in T cells anergized with superantigen and possibly exert an inhibitory effect on IL-2 transcription [83] .
Using an in vivo model of T cell tolerance induced by immunization in the presence of anti-CD40L and a CTLA-4-Ig fusion protein, it has been recently shown that tolerant T cells fail to inactivate Smad3 due to defective phosphorylation by cyclin dependent kinases [15] . In tolerized T cells, these kinases are not properly activated, likely due to the increased levels of p27 kip [15, 84] . Smad3 remains then active, and may inhibit IL-2 expression and proliferation in tolerized T cells. This hypothesis is supported by the fact that adoptively transferred Smad3 knocked-down T cells are resistant to tolerization in this model [15] . Smad3 has been previously shown to mediate TGF-␤-induced inhibition of IL-2 expression in T cells [85] , it is possible then that it may play a similar role in anergic T cells, directly or indirectly inhibiting IL-2 transcription. cAMP-dependent signaling seems to be responsible for p27 kip upregulation in tolerant T cells [84] . These results and the possible inhibitory effect on IL-2 expression of CREB/CREM complexes, suggest that cAMP-mediated signaling may also be an important regulator of the transcriptional mechanisms that control T cell tolerance.
Our laboratory has shown that an active mechanism of transcriptional repression is engaged in anergic Th1 cells. Anergic cells undergo epigenetic changes in the IL-2 promoter locus, leading to a stable inhibition of IL-2 expression [16] . T cells that have been anergized upregulate the expression of Ikaros [7, 16] , a transcription factor with key functions during lymphoid lineage development [86, 87] . Our results indicate that Ikaros may also control mature T cell function. In anergic T cells, Ikaros binds to the IL-2 promoter and recruits histone deacetylases (HDAC), inducing chromatin deacetylation at this locus (Fig. 2 ) [16] . Chromatin remodeling has been suggested to control IL-2 gene expression in T cells. The distal region of the IL-2 promoter shows a partially open conformation in naïve T cells [88] , which is further remodeled, as indicated by increased susceptibility of this locus to nucleases and increased histone acetylation, when IL-2 expression is induced following TCR and CD28 engagement [88, 89] . Increased histone acetylation at the IL-2 promoter seems to require signals derived from CD28 engagement [90] . Active histone deacetylation of the IL-2 promoter occurs in Th1 cells following partial stimulation, which causes stable inhibition of IL-2 transcription. The induction of anergy may thus engage an active program of differentiation that results in the generation of a population of T cells in which a specific pattern of cytokine expression in response to stimulation has been epigenetically imprinted. Regulation of locus accessibility plays also a key role in programs of T cell differentiation such as T helper cell differentiation [57, 91] . Changes in histone acetylation of the IL-4 and IFN␥ genes define stable T cell populations and determine whether those genes will become silent or will be ready to be activated upon stimulation in Th1 or Th2 subpopulations. Whether other chromatin modifications occur concomitantly or are facilitated by histone deacetylation of the IL-2 promoter in anergic T cells remains to be determined. Specific Ikaros binding could also account for some degree of selectivity in the inhibition of cytokine expression in anergic T cells. Further research would also be needed to determine this point. Epigenetic changes may, thus, contribute to induce a stable inactive status on the IL-2 locus, causing a long-lasting inhibition of the IL-2 gene expression in anergic T cells.
Conclusions
Transcriptional mechanisms regulate the two different phases of T cell anergy. First, the induction phase of T cell anergy results from an unbalanced activation of NFAT in the absence of full AP-1 activation caused by suboptimal or partial stimulation. Tolerizing stimuli induce the expression of a Ca 2+ /Cn/NAFTdependent AP-1-independent program of gene expression. Anergy is then implemented and maintained by proteins encoded by those genes. Many of theses proteins, such as the E3 ubiquitin ligases or DGK␣ inhibit T cell function by blocking signaling initiated from the TCR; some others, like Ikaros, actively cause repression of IL-2 transcription of and possibly other cytokines. Keeping self-reactive T cells in check is crucial to prevent autoimmunity, which may explain the existence of multiple complementary mechanisms designed to inhibit self-reactive T cell activation. The characterization of the mechanisms that result in the inhibition of TCR signaling and cytokine transcription, and the identification of the transcriptional complexes that are responsible for the expression of anergy-inducing genes, may help discover new therapeutic targets to modulate T cell function and promote tolerance in the treatment of autoimmune disease and in the prevention of graft rejection.
